Search

everythinglearnresearchcommunity

for

Search:↓

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

Baricitinib significantly improved hair regrowth and quality of life in severe alopecia areata patients.

The treatment was not recommended due to limited effectiveness and significant side effects.

Patients with non-small-cell lung cancer need significant survival gains to accept severe side effects.

Neoadjuvant chemotherapy followed by surgery leads to fewer severe complications and better quality of life than immediate surgery in advanced ovarian cancer patients with high tumor load.

Using 5-aminolevulinic acid photodynamic therapy for hair loss didn't increase hair growth but slightly reduced scalp oiliness, and it was safe with mild side effects.

Baricitinib works better in adolescents than adults for treating severe alopecia areata.

The nutritional supplement Pilopeptan® WOMAN improved hair growth and thickness in women with hair loss.

Baricitinib was effective in treating hair loss in adults with alopecia areata according to patient feedback.

Cromolyn sodium's effectiveness for treating asthma in children under 2 is unclear, possibly more beneficial for older children, and further research is needed.

Sonidegib is effective and safe for treating advanced basal cell carcinoma, but biopsies are needed to confirm tumor clearance.

Systematic end-of-trial biopsies are the most reliable way to assess outcomes.

Neoadjuvant endocrine therapy led to a better future outlook than chemotherapy, with no major quality of life differences.

The scalp lotion helped increase hair thickness in cancer patients undergoing chemotherapy.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

The study aims to find the best platelet-rich plasma dose to relieve moderate carpal tunnel syndrome symptoms.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

Clinical trials for hair loss in the USA show differences in participation among different races and ethnic groups.

RC48 shows promise for treating certain advanced cancers, but more research is needed.

The trial aims to test a new treatment for hair loss in young men using stem cell-derived vesicles.

PRP treatment increased hair density, especially in men and younger patients with AGA.

Bromhexine and spironolactone together reduced COVID-19 symptoms and hospitalization time without side effects.

The trial aims to test if spironolactone is an effective acne treatment for women without the side effects of current treatments.

Topical treatment SM04554 safely promotes hair growth in male baldness.

Completing a 14-day proxalutamide treatment significantly lowers death rates in hospitalized COVID-19 patients.

Autologous Cellular Micrografts effectively treat hair loss with significant improvements and no dangerous side effects.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.